Oral Complications are not only a major cause of pain and suffering for patients undergoing marrow transplantation (BMT), but can also contribute to systemic complications and fatality. Many factors cause or influence the severity of BMT oral complications, including chemoradiotherapy conditioning regimens, oral infections, and acute and chronic GVHD. Little is known about which factors acting singly or in combination are most damaging to oral tissues; the clinical recognition and diagnosis of some complications is unclear, the types and frequency of risks associated with the presence of these complications has yet to be determined. There have been no reported studies on how acute GVHD is manifested in the mouth. Oral acute GVHD frequently goes undetected or is misdiagnosed which can result in delayed diagnosis, compromise overall patient management and lead to increased suffering and risk of other complications. Similar problems exist for oral toxicities resulting from chemoradiotherapy and from oral microbial colonization and infection. We will examine factors likely to influence the frequency and severity of oral complications following BMT. These will include; a) patient-related factors such as patient age, disease, previous therapy, pretransplant oral health, numbers and types of dental restorations and appliances, and oral habits (including smoking) and b) BMT-related factors such as the type and dosage of agents used in BMT conditioning regimens, the use of biological response modifiers, post-BMT immunosuppressive therapy, the rate of engraftment, oral microbial colonization and types of infections, including viral infections, and acute GVHD. The investigators will study these factors through a) the review of prior medical records and medical history, b) frequent detailed clinical examinations, and c) specific laboratory (pathology, microbiology, chemistry, etc.) data. They expect to: a) determine the contribution various risk factors make to the various oral complications observed; b) develop useful diagnostic criteria for diagnosing oral complications of BMT; and c) thus determine oral complication risk profiles for patients. Besides facilitating more expeditious diagnosis of oral complications, these studies will aid in the design of oral care protocols to more efficiently and effectively prevent and/or manage oral problems. They will also enhance understanding of how oral complications can cause or influence systemic complications following BMT.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA038552-05A1
Application #
3807293
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Coda, B A; Brown, M C; Risler, L et al. (1999) Equivalent analgesia and side effects during epidural and pharmacokinetically tailored intravenous infusion with matching plasma alfentanil concentration. Anesthesiology 90:98-108
Coda, B; Tanaka, A; Jacobson, R C et al. (1997) Hydromorphone analgesia after intravenous bolus administration. Pain 71:41-8
Donaldson, G W (1995) The factorial structure and stability of the McGill Pain Questionnaire in patients experiencing oral mucositis following bone marrow transplantation. Pain 62:101-9
Syrjala, K L; Donaldson, G W; Davis, M W et al. (1995) Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain 63:189-98
Bush, N E; Haberman, M; Donaldson, G et al. (1995) Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc Sci Med 40:479-90
Coda, B A; Brown, M C; Schaffer, R L et al. (1995) A pharmacokinetic approach to resolving spinal and systemic contributions to epidural alfentanil analgesia and side-effects. Pain 62:329-37
Lloid, M E; Schubert, M M; Myerson, D et al. (1994) Cytomegalovirus infection of the tongue following marrow transplantation. Bone Marrow Transplant 14:99-104
Coda, B A; Brown, M C; Schaffer, R et al. (1994) Pharmacology of epidural fentanyl, alfentanil, and sufentanil in volunteers. Anesthesiology 81:1149-61
Syrjala, K L; Chapko, M K; Vitaliano, P P et al. (1993) Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 11:319-27
Chapman, C R; Gavrin, J (1993) Suffering and its relationship to pain. J Palliat Care 9:5-13

Showing the most recent 10 out of 40 publications